Therapy for acute heart failure syndromes

Sarah M. Donlan, Erin Quattromani, Peter Pang, Mihai Gheorghiade

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The pharmacologic management of acute heart failure syndromes (AHFS) has changed little over the past 15 years. Traditional therapies, such as nitrates and loop diuretics, remain the mainstay of therapy, with inotropes reserved for patients who present in shock or an advanced low-output state. We review the use of these therapies in AHFS with added insights from recent clinical trials and registry data.

Original languageEnglish (US)
Pages (from-to)192-201
Number of pages10
JournalCurrent Cardiology Reports
Volume11
Issue number3
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Heart Failure
Sodium Potassium Chloride Symporter Inhibitors
Nitrates
Registries
Shock
Therapeutics
Clinical Trials

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Therapy for acute heart failure syndromes. / Donlan, Sarah M.; Quattromani, Erin; Pang, Peter; Gheorghiade, Mihai.

In: Current Cardiology Reports, Vol. 11, No. 3, 2009, p. 192-201.

Research output: Contribution to journalArticle

Donlan, SM, Quattromani, E, Pang, P & Gheorghiade, M 2009, 'Therapy for acute heart failure syndromes', Current Cardiology Reports, vol. 11, no. 3, pp. 192-201. https://doi.org/10.1007/s11886-009-0028-6
Donlan, Sarah M. ; Quattromani, Erin ; Pang, Peter ; Gheorghiade, Mihai. / Therapy for acute heart failure syndromes. In: Current Cardiology Reports. 2009 ; Vol. 11, No. 3. pp. 192-201.
@article{04821b530f934337bc17f0e148480bfb,
title = "Therapy for acute heart failure syndromes",
abstract = "The pharmacologic management of acute heart failure syndromes (AHFS) has changed little over the past 15 years. Traditional therapies, such as nitrates and loop diuretics, remain the mainstay of therapy, with inotropes reserved for patients who present in shock or an advanced low-output state. We review the use of these therapies in AHFS with added insights from recent clinical trials and registry data.",
author = "Donlan, {Sarah M.} and Erin Quattromani and Peter Pang and Mihai Gheorghiade",
year = "2009",
doi = "10.1007/s11886-009-0028-6",
language = "English (US)",
volume = "11",
pages = "192--201",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "3",

}

TY - JOUR

T1 - Therapy for acute heart failure syndromes

AU - Donlan, Sarah M.

AU - Quattromani, Erin

AU - Pang, Peter

AU - Gheorghiade, Mihai

PY - 2009

Y1 - 2009

N2 - The pharmacologic management of acute heart failure syndromes (AHFS) has changed little over the past 15 years. Traditional therapies, such as nitrates and loop diuretics, remain the mainstay of therapy, with inotropes reserved for patients who present in shock or an advanced low-output state. We review the use of these therapies in AHFS with added insights from recent clinical trials and registry data.

AB - The pharmacologic management of acute heart failure syndromes (AHFS) has changed little over the past 15 years. Traditional therapies, such as nitrates and loop diuretics, remain the mainstay of therapy, with inotropes reserved for patients who present in shock or an advanced low-output state. We review the use of these therapies in AHFS with added insights from recent clinical trials and registry data.

UR - http://www.scopus.com/inward/record.url?scp=65549141035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549141035&partnerID=8YFLogxK

U2 - 10.1007/s11886-009-0028-6

DO - 10.1007/s11886-009-0028-6

M3 - Article

C2 - 19379639

AN - SCOPUS:65549141035

VL - 11

SP - 192

EP - 201

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 3

ER -